Is stimulation of prejunctional dopamine receptors an antihypertensive principle? - Wikidata - awgldk - TriplyDB

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

http://www.wikidata.org/entity/Q39665602

about

The role of DA1- and DA2-receptors in the control of blood pressure.

P2860

Q37607713-7B36E027-4557-45F9-92AD-4B9FD8DAAF42

P2860

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

http://www.wikidata.org/entity/Q39665602

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@en

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@nl

type

label

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@en

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@nl

prefLabel

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@en

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@nl

P1433

Q39665602-5651C91C-E309-4805-A430-65C2DD03F94B

P1476

Q39665602-81F8B699-94F7-452A-9D22-9539F8E7A536

P2093

Q39665602-662E2843-9A38-43DA-86E9-65612AC9AE04

P2860

Q39665602-00CCF385-DB5D-460F-A486-4A39D8104B62

Q39665602-03CEBB85-6FC5-420F-ACEE-73C5EA8D1673

Q39665602-0B72BA63-F1ED-4EAD-9419-FBB3BC13BF4B

Q39665602-16D897D9-5F64-4A68-B00A-54C300093721

Q39665602-25B3F52A-D009-4E0E-9821-BA69BA904AA5

Q39665602-4081A643-E913-4099-9CA5-9679D3BF4068

Q39665602-6B3C8AC9-5276-4B5C-939F-664CC71A3E40

Q39665602-93527F9D-F24E-4B6E-8800-FE98B1623A84

Q39665602-98F2107E-8D95-461A-BA89-7A77387E5139

Q39665602-9A4E6953-A993-438B-BF24-F8AF8B6C25FC

P304

Q39665602-97BCBA9F-0B85-490C-974D-99BAD54311B5

P31

Q39665602-19607F29-FFD1-4095-9D98-172ED14D089C

P356

Q39665602-911F7FAC-4F3A-4D9B-91C4-755CA96F46D8

P433

Q39665602-AB50B5BA-774B-4D15-A407-16263ADA0A4C

P478

Q39665602-84DE54BD-4D28-4E31-B74C-D39640DA23BE

P577

Q39665602-D3F8564E-8B0E-4A16-9BD2-C3B3C81CDD12

P698

Q39665602-9A0743E6-CD39-4A4F-B271-5DC4383FA429

P356

10641968709161465

P1433

Clinical and Experimental Hypertension

P1476

Is stimulation of prejunctional dopamine receptors an antihypertensive principle?

@en

P2093

Clark BJ

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of bromocriptine on plasma catecholamines in normal men

The effects of bromocriptine in methyldopa treated hypertension

Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog

Hydrallazine alone in acute left ventricular failure.

Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

[Central hemodynamics of antihypertensive agents. Studies on co-dergocrinmesylate]

Receptors under pressure. An update on baroreceptors.

Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model.

Dopamine receptor profile of co-dergocrine (Hydergine) and its components.

Central dopaminergic mechanisms in young patients with essential hypertension.

P304

1045-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10641968709161465

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

1987-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3304728

http://www.w3.org/2001/XMLSchema#string